These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 33570640)

  • 1. Plasma levels of von Willebrand factor and future risk of incident venous thromboembolism.
    Edvardsen MS; Hindberg K; Hansen ES; Morelli VM; Ueland T; Aukrust P; Brækkan SK; Evensen LH; Hansen JB
    Blood Adv; 2021 Jan; 5(1):224-232. PubMed ID: 33570640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the von Willebrand factor-ADAMTS-13 axis on the risk of future venous thromboembolism.
    Edvardsen MS; Hansen ES; Ueland T; Aukrust P; Brækkan SK; Morelli VM; Hansen JB
    J Thromb Haemost; 2023 May; 21(5):1227-1237. PubMed ID: 36736832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated plasma D-dimer levels are associated with risk of future incident venous thromboembolism.
    Hansen ES; Rinde FB; Edvardsen MS; Hindberg K; Latysheva N; Aukrust P; Ueland T; Michelsen AE; Hansen JB; Brækkan SK; Morelli VM
    Thromb Res; 2021 Dec; 208():121-126. PubMed ID: 34763296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined effects of plasma von Willebrand factor and platelet measures on the risk of incident venous thromboembolism.
    Edvardsen MS; Hansen ES; Hindberg K; Morelli VM; Ueland T; Aukrust P; Brækkan SK; Evensen LH; Hansen JB
    Blood; 2021 Dec; 138(22):2269-2277. PubMed ID: 34161566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma levels of growth differentiation factor 15 are associated with future risk of venous thromboembolism.
    Hansen ES; Hindberg K; Latysheva N; Aukrust P; Ueland T; Hansen JB; Brækkan SK; Morelli VM;
    Blood; 2020 Oct; 136(16):1863-1870. PubMed ID: 32645137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated plasma levels of plasminogen activator inhibitor-1 are associated with risk of future incident venous thromboembolism.
    Frischmuth T; Hindberg K; Aukrust P; Ueland T; Braekkan SK; Hansen JB; Morelli VM
    J Thromb Haemost; 2022 Jul; 20(7):1618-1626. PubMed ID: 35289062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma levels of platelet-derived microvesicles are associated with risk of future venous thromboembolism.
    Snir O; Wilsgård L; Latysheva N; Wahlund CJE; Braekkan SK; Hindberg K; Hansen JB
    J Thromb Haemost; 2022 Apr; 20(4):899-908. PubMed ID: 35000275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma levels of mannose-binding lectin and future risk of venous thromboembolism.
    Liang RA; Høiland II; Ueland T; Aukrust P; Snir O; Hindberg K; Braekkan SK; Garred P; Mollnes TE; Hansen JB
    J Thromb Haemost; 2019 Oct; 17(10):1661-1669. PubMed ID: 31220397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ADAMTS-13 and von Willebrand factor predict venous thromboembolism in patients with cancer.
    Pépin M; Kleinjan A; Hajage D; Büller HR; Di Nisio M; Kamphuisen PW; Salomon L; Veyradier A; Stepanian A; Mahé I
    J Thromb Haemost; 2016 Feb; 14(2):306-15. PubMed ID: 26589836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma levels of P-selectin and future risk of incident venous thromboembolism.
    Swamy S; Ueland T; Hansen JB; Snir O; Brækkan SK
    J Thromb Haemost; 2023 Sep; 21(9):2451-2460. PubMed ID: 37182696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement activation assessed by the plasma terminal complement complex and future risk of venous thromboembolism.
    Høiland II; Liang RA; Braekkan SK; Pettersen K; Ludviksen JK; Latysheva N; Snir O; Ueland T; Hindberg K; Mollnes TE; Hansen JB
    J Thromb Haemost; 2019 Jun; 17(6):934-943. PubMed ID: 30920726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma Levels of Leptin and Risk of Future Incident Venous Thromboembolism.
    Frischmuth T; Hindberg K; Aukrust P; Ueland T; Brækkan SK; Hansen JB; Morelli VM
    Thromb Haemost; 2022 Apr; 122(4):560-569. PubMed ID: 34264516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Traditional Cardiovascular Risk Factors With Venous Thromboembolism: An Individual Participant Data Meta-Analysis of Prospective Studies.
    Mahmoodi BK; Cushman M; Anne Næss I; Allison MA; Bos WJ; Brækkan SK; Cannegieter SC; Gansevoort RT; Gona PN; Hammerstrøm J; Hansen JB; Heckbert S; Holst AG; Lakoski SG; Lutsey PL; Manson JE; Martin LW; Matsushita K; Meijer K; Overvad K; Prescott E; Puurunen M; Rossouw JE; Sang Y; Severinsen MT; Ten Berg J; Folsom AR; Zakai NA
    Circulation; 2017 Jan; 135(1):7-16. PubMed ID: 27831499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated plasma concentration of complement factor C5 is associated with risk of future venous thromboembolism.
    Skjeflo EW; Brækkan SK; Ludviksen JK; Snir O; Hindberg K; Mollnes TE; Hansen JB
    Blood; 2021 Nov; 138(21):2129-2137. PubMed ID: 34339498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma lipopolysaccharide-binding protein is a biomarker for future venous thromboembolism: Results from discovery and validation studies.
    Jensen SB; Latysheva N; Hindberg K; Ueland T
    J Intern Med; 2022 Sep; 292(3):523-535. PubMed ID: 35426199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum levels of vitamin D are not associated with future risk of venous thromboembolism. The Tromsø Study.
    Brodin E; Lerstad G; Grimnes G; Brækkan SK; Vik A; Brox J; Svartberg J; Jorde R; Hansen JB
    Thromb Haemost; 2013 May; 109(5):885-90. PubMed ID: 23446951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Levels of Complement Activating Enzyme MASP-2 Are Associated With the Risk of Future Incident Venous Thromboembolism.
    Damoah CE; Snir O; Hindberg K; Garred P; Ludviksen JK; Brækkan SK; Morelli VM; Mollnes TE; Hansen JB;
    Arterioscler Thromb Vasc Biol; 2022 Sep; 42(9):1186-1197. PubMed ID: 35861070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High factor VIII, von Willebrand factor, and fibrinogen levels and risk of venous thromboembolism in blacks and whites.
    Payne AB; Miller CH; Hooper WC; Lally C; Austin HD
    Ethn Dis; 2014; 24(2):169-74. PubMed ID: 24804362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High microRNA-145 plasma levels are associated with decreased risk of future incident venous thromboembolism: the HUNT study.
    Morelli VM; Snir O; Hindberg KD; Hveem K; Brækkan SK; Hansen JB
    Blood; 2024 Apr; 143(17):1773-1781. PubMed ID: 38211336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of testing for cancer on cancer- and venous thromboembolism (VTE)-related mortality and morbidity in people with unprovoked VTE.
    Robertson L; Yeoh SE; Stansby G; Agarwal R
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD010837. PubMed ID: 28832905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.